Phase I study of ceralasertib (cerala) in combination with AZD5305 in patients (pts) with advanced/metastatic ovarian cancer (OC) previously treated with PARP inhibitors (PARPis) Meeting Abstract
| Authors: | Shapiro, G. I.; Basu, B.; El-Khoueiry, A. B.; Postel-Vinay, S.; Im, S. A.; Rha, S. Y.; Friedman, C. F.; Italiano, A.; Kim, Y. M.; Lim, M. C.; Roux, R.; Liu, J. F.; Brown, M.; Webb, B. W.; Lukashchuk, N.; Dean, E. J.; Nehra, J.; Loembé, B.; Krebs, M. G. |
| Abstract Title: | Phase I study of ceralasertib (cerala) in combination with AZD5305 in patients (pts) with advanced/metastatic ovarian cancer (OC) previously treated with PARP inhibitors (PARPis) |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S542 |
| Language: | English |
| ACCESSION: | WOS:001087480201158 |
| DOI: | 10.1016/j.annonc.2023.09.1996 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 821TiP -- Source: Wos |
